Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome
- PMID: 22417946
- PMCID: PMC3572196
- DOI: 10.1016/j.bbi.2012.02.008
Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome
Abstract
Objectives: Stressors and emotional distress responses impact chronic fatigue syndrome (CFS) symptoms, including fatigue. Having better stress management skills might mitigate fatigue by decreasing emotional distress. Because CFS patients comprise a heterogeneous population, we hypothesized that the role of stress management skills in decreasing fatigue may be most pronounced in the subgroup manifesting the greatest neuroimmune dysfunction.
Methods: In total, 117 individuals with CFS provided blood and saliva samples, and self-report measures of emotional distress, perceived stress management skills (PSMS), and fatigue. Plasma interleukin-1-beta (IL-1β, IL-2, IL-6, IL-10, and tumor necrosis factor-alpha (TNF-α), and diurnal salivary cortisol were analyzed. We examined relations among PSMS, emotional distress, and fatigue in CFS patients who did and did not evidence neuroimmune abnormalities.
Results: Having greater PSMS related to less fatigue (p=.019) and emotional distress (p<.001), greater diurnal cortisol slope (p=.023) and lower IL-2 levels (p=.043). PSMS and emotional distress related to fatigue levels most strongly in CFS patients in the top tercile of IL-6, and emotional distress mediated the relationship between PSMS and fatigue most strongly in patients with the greatest circulating levels of IL-6 and a greater inflammatory (IL-6):anti-inflammatory (IL-10) cytokine ratio.
Discussion: CFS patients having greater PSMS show less emotional distress and fatigue, and the influence of stress management skills on distress and fatigue appear greatest among patients who have elevated IL-6 levels. These findings support the need for research examining the impact of stress management interventions in subgroups of CFS patients showing neuroimmune dysfunction.
Copyright © 2012 Elsevier Inc. All rights reserved.
Figures
References
-
- Addington JW. Chronic fatigue syndrome: a dysfunction of the hypothalamic–pituitary–adrenal axis. J Chron Fatigue Synd. 2000;7 (2):63–73.
-
- Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, Ayala AR, Licinio J, Gold HK, Kling MA, Chrousos GP, Gold PW. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab. 2005;90:2522–2530. - PubMed
-
- Al-Harthi L, Wright DJ, Anderson D, Cohen M, Matity, Ahu D, Cohn J, Cu-Unvin S, Burns D, Reichelderfer P, Lewis S, Beckner S, Kovacs A, Landay A. The impact of the ovulatory cycle on cytokine production: evaluation of systemic, cervicovaginal, and salivary compartments. J Interferon Cytokine Res. 2000;20:719–724. - PubMed
-
- Antoni MH. Stress management, psychoneuroimmunology and disease. In: Segerstrom S, editor. Psychoneuroimmunology. Oxford; NY: pp. 1121–1228. in press.
-
- Antoni MH, Weiss D. Stress, immunity, and chronic fatigue syndrome: a conceptual model to guide the development of treatment and research. In: Jason LA, Fennell PA, Taylor RR, editors. Handbook of Chronic Fatigue Syndrome and Fatiguing Illnesses. Wiley; New York: 2003.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
